ENDRA Life Sciences Inc’s filing revealed that its 10% Owner UBS Group AG acquired Company’s shares for reported $2052.0 on Aug 27 ’24. In the deal valued at $0.55 per share,3,715 shares were bought. As a result of this transaction, UBS Group AG now holds 146,012 shares worth roughly $0.49 million.
Price Performance Review of NDRA
On Monday, ENDRA Life Sciences Inc [NASDAQ:NDRA] saw its stock fall -8.45% to $3.36. Over the last five days, the stock has lost -8.70%. ENDRA Life Sciences Inc shares have fallen nearly -46.33% since the year began. Nevertheless, the stocks have fallen -99.17% over the past one year. While a 52-week high of $664.82 was reached on 01/03/25, a 52-week low of $3.02 was recorded on 04/16/25. SMA at 50 days reached $4.15, while 200 days put it at $27.05.
Levels Of Support And Resistance For NDRA Stock
The 24-hour chart illustrates a support level at 3.17, which if violated will result in even more drops to 2.99. On the upside, there is a resistance level at 3.66. A further resistance level may holdings at 3.97. The Relative Strength Index (RSI) on the 14-day chart is 43.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.14%. Stochastics %K at 17.47% indicates the stock is a buying.
How much short interest is there in ENDRA Life Sciences Inc?
A steep rise in short interest was recorded in ENDRA Life Sciences Inc stocks on 2025-03-31, growing by 3246.0 shares to a total of 31580.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 28334.0 shares. There was a rise of 10.28%, which implies that there is a positive sentiment for the stock.
